Limited and External Funding Opportunity Announcements

General guidelines for Limited Submissions


Active Internal Calls for Limited Submission Nominations 

VUMC Limited Submission Opportunity: NIMHD Specialized Centers of Excellence on Minority Health and Health Disparities (U54, RFA-MD-17-005)

Proposals due March 27th 

Vanderbilt University Medical Center may submit one application to the NIMHD Specialized Centers of Excellence on Minority Health and Health Disparities (U54) funding program. The purpose of this FOA is to further advance NIMHD’s mission by supporting Centers of Excellence to conduct transdisciplinary, multi-level research and to provide research opportunities for post-doctoral fellows, junior faculty, and other early stage investigators to engage in this type of research.

The thematic focus must revolve around one or more NIH-designated health disparity populations, which include Blacks/African Americans, Hispanics/Latinos, American Indians/Alaska Natives, Asian Americans, Native Hawaiians and Other Pacific Islanders, socioeconomically disadvantaged populations, underserved rural populations, and sexual and gender minorities. This focus may include multiple health disparity populations, a single health disparity population, or a subgroup within a health disparity population. The thematic focus may involve:

  • Specific disease areas that disproportionately affect disparity populations and contribute substantially to health outcomes
  • Prevention topics that cut across health conditions and populations
  • Life course groups that incorporate selected components from above
  • Understanding the etiology and mechanisms of diseases and health conditions in health disparity populations
  • Evaluating intervention approaches to improve minority health or reduce health disparities
  • Developing methodological approaches or addressing measurement issues

The award budget is limited to a total of $950K in direct costs per year, for a total $4.75M over the 5 year project period.

Interested VUMC PIs are encouraged to consider opportunities for collaboration across all School of Medicine departments (both VUMC and VU) as appropriate to the thematic focus.  Internal proposals will be forwarded to a VUMC faculty committee for review and recommendation to select the most competitive VUMC application to this program. 

Any VUMC investigators interested in applying to this program must submit the following (compiled in a single PDF) to LSO@vanderbilt.edu by 5pm on March 27, 2017:

  • Brief (2 page maximum) research plan including short description of the required cores, list of key personnel and summary budget;
  • Brief statement of support from department chair/center director;
  • CV or NIH Biosketch

Submissions should reference the program name in the subject line of the email. 

Please direct any questions to Susan Meyn in the VUMC Office of Research.  


2017 Takeda Innovators in Science Award

Proposals due March 27th

VUMC has been invited to nominate up to two candidates for the 2017 Takeda Innovators in Science Award. Sponsored by the Takeda Pharmaceutical Company Limited and administered by the New York Academy of Sciences, this award was established in November 2016 and recognizes a promising Early Career Scientist and an outstanding Senior Scientist’s contributions to science in the therapeutic areas of Neuroscience, Gastroenterology, Regenerative Medicine, and Oncology; and is intended to support their commitment to innovative research. Two prizes of US$200,000 are awarded each year, in a specific therapeutic area, one to an Early Career Scientist and the other to a well-established Senior Scientist from across the globe who have distinguished themselves for the creative thinking and impact of their research.

Eligibility of the Early-Career Scientist

The nominee must:

  • Have been engaged in active research for a length of time of 10 years or less since gaining their doctorate degree or equivalent.
  • Hold a doctorate degree (PhD, DPhil, MD, DDS, DVM, etc.).
  • Currently hold a junior level Post-doctoral or Faculty position at an invited academic, government, or non-profit institution or equivalent.
  • Have made impactful research contributions and show exceptional promise for significant future achievement in the Award field.

Eligibility of the Senior Scientist

The nominee must:

  • Have been engaged in active research for a length of time of 15 years or longer since gaining their doctorate degree or equivalent.
  • Hold a doctorate degree (PhD, DPhil, MD, DDS, DVM, etc.).
  • Currently hold a senior level Faculty position at an invited academic, government, or non-profit institution or equivalent.
  • Have made multiple, extensive, and impactful research contributions to advance the Award field.

Anyone interested in being considered as a VUMC nominee must submit the following (in PDF format) to LSO@vanderbilt.edu by 5:00 p.m. on Monday, March 27, 2017. 

  • Brief (2 page maximum) research plan including summary budget;
  • Brief statement of support from department chair/center director;
  • Brief CV or NIH Biosketch

Submissions should reference the program name in the subject line of the email. Applicants are encouraged to review full details on the foundation website.

Once received, all proposals will be forwarded to an internal review committee that will choose the final nominee. The chosen nominee will submit a full proposal to the Foundation in April.

If you have any questions about the Foundation or its interests and priorities, please contact Megan Smallwood, Program Manager, VUMC Office of Research. 


V Foundation 2017 V Scholar Award

Proposals due April 12th

Vanderbilt Ingram Cancer Center (VICC) has been invited to participate in The V Foundation 2017 V Scholar Award. The V Scholar award is a $200,000 grant awarded in two annual installments of $100,000. Only direct costs of the research are supported by this award.

VUMC may nominate up to two candidates for this award, if at least one of the two nominee applicants identifies as someone from an underrepresented in science minority (for the purposes of this application: African American or of African descent, Hispanic American, or Native American, and/or Alaskan Native). 

As in 2016, we are continuing to raise funds to support the Stuart Scott Memorial Cancer Research Fund initiative. Among our highly ranked finalists for the 2017 V Scholar program, we will designate at least one of the highest ranked applications from a minority applicant as the recipient of a 2017 Stuart Scott Memorial Fund V Scholar Award.

Special Focus area: Any area of cancer research is eligible.

Applicant Eligibility:  

All nominated applicants must meet all of the following criteria to be eligible to submit an application:

  • Applicant must have at least 2 years post-doctoral (MD or PhD) fellowship training. For MDs, a minimum of one year is acceptable if only one year is required for the specialty.

By the Due Date of the Application, applicants must have all the following:

  • Hold a tenure-track faculty position as an assistant professor at their cancer research institution. Non-promotable, adjunct, affiliated, temporary, part-time or acting faculty positions are not eligible for this grant competition.
  • Have been appointed to their first full-time assistant professor position within the last 5 years, and not yet been promoted to Associate Professor.
  • Clinical scientists are eligible if the research institution can demonstrate that it will fully support the research applicant (e.g., dedicated lab space, start-up funds, dedicated research time).
  • Applicants must be either US Citizens or be a permanent legal resident in the US.

Applicant can NOT already have been awarded an RO1 or RO1-equivalent grants. As of the Due Date of the Application, applicants who have been awarded RO1 equivalent grants (Project leader on an NIH multi-investigator grant, ACS) as principal investigators or as co-leader at the time of application submission are not eligible for consideration as a V Scholar. In addition, applicants cannot be a co-leader on a SPORE project or (co)PI of the following NIH grant mechanisms: U01, DP1, DP2, R37, R23. In addition, principal investigators for research project grants (RPGs), analogous to NIH/NCI R01 awards, would be ineligible.

Anyone interested in being considered as Vanderbilt’s nominee must submit the following (in PDF format) to LSO@vanderbilt.edu  by 5 p.m. on Wednesday, April 12, 2017.

  • Brief (2 page maximum) research plan including summary budget;
  • Brief statement of support from department chair/center director;
  • A brief CV or NIH Biosketch

Submissions should reference the program name in the subject line of the email. 

Once received, all proposals will be forwarded to an internal review committee that will choose the final nominee. The chosen nominee will submit a full proposal to the Foundation by the June 1, 2017 deadline.

If you have any questions about the Foundation or its interests and priorities, please contact Megan Smallwood, Program Manager in the Office of Research.


Active Internal Calls for NON-Limited External Nominations 

Alliance for Cancer Gene Therapy (ACGT)'s 2017 Investigator's Award in Clinical Translation of Cell and Gene Therapies for Cancer​

LOIs due March 21, 2017

The Fund for Advancement award grants $500,000 to Principal Investigators conducting translational research that will move cell and gene therapies from the laboratory towards clinical trials.

Eligibility:

Candidates must hold an MD, PhD, or equivalent degree and be a tenure-track or tenured faculty. The investigator must be conducting original research as an independent faculty member. ACGT has no citizenship restrictions; however, research supported by the award must be conducted at medical schools and research centers in the United States and Canada. Entering into clinical translation during the funding period is a requirement. Continued support is contingent upon submission and approval of a non-competitive renewal application each year.

Please visit the website for application details and instructions for submission.


Pfizer Independent Grants for Learning & Change (IGLC): Request for Proposals (RFP) - Rheumatology Fellowships

Applications due March 24, 2017 

Amount Upper  $160,000USD

Individual requests for fellowship grants up to $80,000 per year for up to two years will be considered. Funding is to be used as a salary supplement for a fellow at the recipient organization. Funding will be awarded to the organization, which will select the recipient. Funding must be used primarily as salary support for the selected fellow, not for overhead, indirect or fringe costs. U.S. Physician Payments Sunshine Act ("Sunshine Act") and other transparency law reporting requirements must be satisfied with respect to meals, payments, travel and other transfers of value. Program start date must be after June 1, 2017. Fellowships funded in 2017 must be completed before December 31, 2020. Grants will be distributed following execution of fully signed Letter of Agreement.

Applicant Type:  Academic Institution, New Faculty/New Investigator

Abstract: The mission of Pfizer Independent Grants for Learning & Change (IGLC) is to partner with the global healthcare community to improve patient outcomes in areas of mutual interest through support of measurable learning and change strategies. "Independent" means that the projects funded by Pfizer are the full responsibility of the recipient organization. Pfizer has no influence over any aspect of the projects and only asks for reports about the results and the impact of the projects in order to share them publicly.

The Pfizer Fellowship Program ("Fellowship Program") is a reflection of Pfizer's commitment to advancing research, innovation, clinical expertise and medical education for medical, nursing, and allied health professionals. This program provides career-building opportunities for practicing clinicians and academic researchers in outcomes and patient-oriented research that is vital to improving healthcare.

The intent of this Request for Proposal (RFP) is to encourage organizations with an active rheumatology fellowship program to submit a proposal. The purpose of the Fellowship Program grant is to provide support the continued training of fellows in any year of a program focused on research. Organizations seeking funding must submit proposals describing the strength of their program in supporting clinical training and research.

Geographic scope: United States Only

Clinical area: Rheumatology

Specific Area of Interest: It is Pfizer's intent to support institutions with adult rheumatology fellowship programs that have a strong focus on clinical practice, research, and education to further the understanding of rheumatic diseases.

Grants will be awarded based on the strength of the requesting organization's ability to provide training and guidance to the fellow. Priority will be given to applications demonstrating the most need.

Requirements for Prospective Fellows

  • Prospective award recipients at the organization cannot apply directly for the award. However, a fellow may assist the senior staff, division head or department chair at the organization in the development of the application.
  • Fellows supported by a Pfizer fellowship must have the opportunity to carry out supervised research with the primary objective preparation for their respective discipline and subspecialty.
  • Upon receipt of the award, the fellow selected by the organization must meet the following criteria: U.S. citizen or foreign national with permanent U.S. residence; hold an advanced degree (e.g., PhD, MD, DO, NP, PharmD, etc.).

Requirements for Research Projects

This grant opportunity is to support fellows involved with independent research that seeks to improve the organization, financing and/or delivery of strategies and initiatives that promote health and prevent disease and disability in patients with rheumatic diseases. Examples of such research include, but are not limited to: observational studies and outcomes research studies where the primary focus is the scientific understanding of disease; novel approaches to implementing improvements in practice; use of screening tools and their impact on improvement of patient health. Examples of research that would be ineligible include research involving the study and/or evaluation of any pharmaceutical product and basic science and/or fundamental research (in animal model, invitro, etc.).

Eligibility

The following requirements are in place for the Fellowship:

  • Application must be submitted by an accredited U.S.-based academic organization.
  • The organization cannot host more than one fellow funded through this same award during the proposed term.
  • Senior staff, division heads or department chairs and fellowship directors should work on behalf of their organization to prepare and submit an application for consideration.
  • Applicants should not include the name of the potential fellow in application materials. This is an organizational grant and the attributes of an individual fellow will not be taken into consideration.

The Franklin Institute Bower Award and Prize for Achievement in Science

Applications due May 31, 2017

Theme: Genome Editing

Prize: $250,000 

The Franklin Institute seeks nominations for the 2018 Bower Award and Prize for Achievement in Science of individuals who have made significant contributions to our understanding or the development of genome editing and/or its applications. Nominations may recognize contributions including, but not limited to, the discovery/elucidation of genome editing mechanisms such as those involving CRISPR, TALENs, or zinc finger nucleases; genome editing tool development; or genome editing for basic research or applied outcomes in a variety of systems (e.g. for crop improvement or medical therapeutics). Nominations must clearly indicate the scientific impact of the nominee’s work, whether conceptual, technical, or integrative.

Eligibility:

  • This is an international competition for individuals who have made significant contributions to our understanding or the development of genome editing and/or its applications.
  • This award and prize must be presented to an individual, as specified by the will of Henry Bower.
  • Candidates must be living, and the winner must participate in The Franklin Institute Awards Week programs, to be held in April 2018 in Philadelphia, Pennsylvania, USA.
  • Self-nominations are accepted.

Please visit the website for application details and instructions for submission.


Eppendorf & Science Prize for Neurobiology

Applications due June 15, 2017

The Prize is awarded annually to one young scientist for the most outstanding neurobiological research based on methods of molecular and cell biology conducted by him/her during the past three years.

Prize money: $25,000

Rules of Eligibility

  • Entrants must be a neurobiologist with an advanced degree received in the last 10 years and not older than 35 years of age.
  • The entrant's essay must describe contributions to neurobiological research based on methods of molecular and cell biology.
  • The entrant must have performed or directed the work described in the essay.
  • The research must have been performed during the previous three years.

Please visit the website for application details and instructions for submission.


Merck Investigator Studies Program (MISP)

LOIs reviewed on an ongoing basis. There are no deadlines.

Amount: The amount is not specified. Financial and/or product support is contingent upon full execution by both parties of the research agreement.

Applicant Type: Graduate Student, New Faculty/New Investigator, Ph.D./M.D./Other Professional

Abstract: The Mission Statement is to advance science and improve patient care by supporting, through the provision of drug/vaccine and/or total/partial funding, high-quality research that is initiated, designed, implemented and sponsored by external investigators. Results will be generated and properly disseminated in peer-reviewed publications.

This program consists of committees of medical and scientific staff from different therapeutic areas who meet regularly to review Merck investigator study proposals. Support is provided based on the scientific merit of the proposal as well as whether it is in alignment with the published areas of interest. Information related to areas of interest and requirements for submission can be found by clicking on the appropriate link for your therapeutic area.

The current MISP areas supported are:

  • Cardiovascular
  • Endocrinology
  • Health Literacy/Diversity/Adherence
  • Infectious Disease
  • Merck for Mothers
  • Neuroscience
  • Oncology
  • Respiratory/Allergy
  • Surgery
  • Women's Health
  • Vaccines

Eligibility: The Merck Investigator Studies Program is open to all academic and community-based physicians and researchers worldwide who are interested in conducting their own research.


Walmart Foundation National Giving Program

LOIs reviewed on an ongoing basis. There are no deadlines.

The underlying focus in all of the Walmart Foundation's work is on empowering low-income people to help them live better. This program allows the Foundation to work strategically with organizations working across one or more states to address social issues strongly aligned with the Foundation's focus areas. 

The program awards grants of $250,000 and above. Overhead/indirect costs (i.e., non-program-related expenses) may not exceed 10% of the total program budget. Walmart and the Walmart Foundation do not currently award multi-year commitments. Organizations may, however, propose initiatives with timeframes that extend up to two years. No-cost extensions may be requested for up to an additional 12 months, if necessary. 

Please visit the website for application details and instructions for submission.